Skip to main content
. 2015 Oct;6(5):516–523. doi: 10.3978/j.issn.2078-6891.2015.040

Table 1. Patient and tumor characteristics.

Characteristics No RT, n=14,401 (%) Yes RT, n=26,377 (%) P value
Median follow-up (years) 1.4 1.25
Age (years) <0.0001
  <50 1,179 (8.2) 2,079 (7.9)
  50-59 2,885 (20.0) 5,833 (22.1)
  60-69 4,409 (30.6) 8,545 (32.4)
  70-80 3,851 (26.7) 6,934 (26.3)
  80+ 2,077 (14.4) 2,986 (11.3)
Gender 0.0002
  Female 3,370 (23.4) 6,603 (25.0)
  Male 11,031 (76.6) 19,774 (75.0)
Race <0.0001
  White 12,235 (85.0) 21,039 (79.8)
  Black 1,404 (9.7) 3,927 (14.9)
  Other* 687 (4.8) 1,383 (5.2)
  Unknown 75 (0.5) 31 (0.1)
Year of diagnosis <0.0001
  Prior to 1990 2,063 (14.3) 4,774 (18.1)
  1990-1999 2,713 (18.8) 5,365 (20.3)
  2000-2011 9,625 (66.8) 16,238 (61.6)
SEER historic staging <0.0001
  Localized** 5,115 (35.5) 7,155 (27.1)
  Regional*** 3,424 (23.8) 9,814 (37.2)
  Distant 3,273 (22.7) 5,865 (22.2)
  Unstaged 2,589 (18.0) 3,543 (13.4)
Location <0.0001
  Cervical/upper thoracic 768 (5.3) 3,069 (11.6)
  Middle thoracic 2,273 (15.8) 5,931 (22.5)
  Lower thoracic 9,049 (62.8) 14,651 (55.5)
  Thoracic 357 (2.5) 989 (3.7)
  NOS 1,954 (13.6) 1,737 (6.6)
Extent of surgery <0.0001
  Esophagectomy 9,568 (66.4) 10,288 (39.0)
  Other 4,833 (33.6) 16,086 (61.0)

*, other race includes American Indian, Alaskan Native, Asian and Pacific Islander; **, localized defined as T1 or T2 with negative nodes; ***, regional defined as T3 or T4 with negative nodes or any T stage with positive nodes. RT, radiation therapy.